The Hengeler team – led by capital markets and corporate partner Torsten Busch – guided Fresenius as the company issued 13.8 million new shares with gross proceeds of approximately €1 billion.
The capital increase is the first component involved in financing for the planned acquisition of leading German private hospital group Rhon-Klinikum, on which Hengeler Mueller also advised.
Email your news and story ideas to: [email protected]
